M. Lagging
Erasmus University Rotterdam
6 Papers
39 Citations
M. Lagging is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Ribavirin & Hepatitis C. The author has an hindex of 4, co-authored 6 publications.
Chat about Author
Papers
CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT HCV-Specific T-Cell Response in Relation to Viral Kinetics and Treatment Outcome (DITTO-HCV Project)
Massimo Pilli,Alessandro Zerbini,Amalia Penna,Alessandra Orlandini,Esther Lukasiewicz,Stefan Zeuzem,S.W. Schalm,Michael von Wagner,Georgios Germanidis,Yoav Lurie,Juan Ignacio Esteban,Bart L. Haagmans,Christophe Hézode,M. Lagging,Francesco Negro,Yonit Homburger,Avidan U. Neumann,Carlo Ferrari,Gabriele Missale +18 more
- 01 Jan 2007
TL;DR: The second slope of viral decline induced by interferon treatment has been suggested to be influenced mainly by the hepatitis C virus (HCV)-specific T-cell response; however, this hypothesis needs to be validated by results derived from experimental studies as discussed by the authors.
41
2011 IL28B POLYMORPHISM IS SIGNIFICANTLY CORRELATED WITH IFN ANTI-VIRAL EFFECTIVENESS ALREADY ON FIRST DAY OF PEGYLATED INTERFERON-α AND RIBAVIRIN THERAPY OF CHRONIC HCV INFECTION
Avidan U. Neumann,Stéphanie Bibert,Bart L. Haagmans,Alexandre Soulier,F. Negro,M. Lagging,C. Ferrari,S. Zeuzem,J.-M. Pawlotsky,S.W. Schalm,Pierre-Yves Bochud +10 more
13
Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at day 0, day 22, day 29, and week 6
Esther Lukasiewicz,Esther Lukasiewicz,Kristoffer Hellstrand,Johan Westin,Carlo Ferrari,Avidan U. Neumann,Avidan U. Neumann,Jean-Michel Pawlotsky,Jean-Michel Pawlotsky,Solko W. Schalm,Stefan Zeuzem,Stefan Zeuzem,Bart J. Veldt,Bettina E. Hansen,Elke Verhey-hart,M. Lagging +15 more
TL;DR: The use of AST and ALT levels as times the upper limit of normality in the calculation of FIB-4 is suggested, which can expand its applicability to populations with different reference ranges for aminotransferases.
9
10 ribavirin concentration at week four is an independend predictor for sustained virological response after treatment of hepatitis c genotype 2/3 (nordynamic trial)
Peer Brehm Christensen,Åsa Alsiö,Mads Rauning Buhl,Martti Färkkilä,Kristine Mørch,Per Sangfelt,M. Lagging,Gunnar Norkrans,Court Pedersen +8 more
9
317 International multicenter, randomized, controlled study comparing standard versus dynamically individualized treatment in patients with chronic hepatitis C (DITTO-HCV) project)
Stefan Zeuzem,Jean-Michel Pawlotsky,E Hagai,Ioannis Goulis,Yoav Lurie,E Gianfranco,Juan Ignacio Esteban,Christophe Hézode,M. Lagging,Alexandre Soulier +9 more
7